会员体验
专利管家(专利管理)
工作空间(专利管理)
风险监控(情报监控)
数据分析(专利分析)
侵权分析(诉讼无效)
联系我们
交流群
官方交流:
QQ群: 891211   
微信请扫码    >>>
现在联系顾问~
热词
    • 12. 发明申请
    • Methods for identifying modulators of kinesin activity
    • 识别驱动蛋白活性调节剂的方法
    • US20070134660A1
    • 2007-06-14
    • US10558463
    • 2004-05-28
    • Mao MaoPeter LinsleyCarolyn BuserChristopher Marshall
    • Mao MaoPeter LinsleyCarolyn BuserChristopher Marshall
    • C12Q1/68G01N33/574A61K31/175
    • G01N33/5011A61K31/175A61K38/00C12Q1/34G01N33/573G01N33/57415
    • In a first aspect, the invention provides methods for screening for modulators of a target protein, comprising the steps of contacting a target protein with a candidate agent and determining whether the candidate agent modulates the activity of the target protein, wherein the target protein comprises a sequence that has more than 80% amino acid sequence identity to KIF14 (SEQ ID NO:2) or the KIF14 motor domain (SEQ ID NO:3). In a second aspect, the invention provides methods for modulating cell proliferation comprising administering to a cell an effective amount of a modulator of the activity of a target protein. Some embodiments of this aspect provide methods for treating a subject with a cellular hyperproliferation disorder, such as cancer. In a third aspect, the invention provides methods for identifying candidate subjects for treatment with an inhibitor of the activity of a target protein.
    • 在第一方面,本发明提供了筛选靶蛋白的调节剂的方法,包括以下步骤:使靶蛋白与候选试剂接触并确定候选试剂是否调节靶蛋白的活性,其中靶蛋白包含 与KIF14(SEQ ID NO:2)或KIF14运动结构域(SEQ ID NO:3)具有80%以上氨基酸序列同一性的序列。 在第二方面,本发明提供了调节细胞增殖的方法,包括向细胞施用有效量的靶蛋白活性的调节剂。 该方面的一些实施方案提供了用细胞过度增殖病症如癌症治疗受试者的方法。 在第三方面,本发明提供用于鉴定候选受试者用靶蛋白活性抑制剂治疗的方法。
    • 14. 发明申请
    • Human diaphanous-3 gene and methods of use therefor
    • 人类透明-3基因及其使用方法
    • US20050054826A1
    • 2005-03-10
    • US10848755
    • 2004-05-18
    • Mao Mao
    • Mao Mao
    • C07H21/04C07K14/47C07K14/705
    • C07K14/705C07H21/04C07K14/4738
    • The present invention is directed to the full-length cDNA sequence encoding human diaphanous-3 (DIAPH3), to DIAPH3 encoded thereby, and to fragments of DIAPH3 and the cDNA. The present invention also provides for the use of the cDNA, and of DIAPH3, as a marker of poor prognosis of breast cancer. Because DIAPH3 appears essential for proper spindle pole formation during mitosis, DIAPH3 is a useful target for screening assays designed to identify inhibitors or modulators of DIAPH3 activity, which are useful for the treatment of cancer, particularly breast cancer. Thus, the invention further provides methods of using DIAPH3, or fragments thereof, in assays to identify such compounds.
    • 本发明涉及编码人透皮质-3(DIAPH3)的全长cDNA序列,由此编码的DIAPH3以及DIAPH3和cDNA片段。 本发明还提供了使用cDNA和DIAPH3作为乳腺癌预后差的标志物。 因为DIAPH3对于在有丝分裂期间正确的心轴形成是必不可少的,所以DIAPH3是用于筛选测定的有用靶标,用于鉴定用于治疗癌症,特别是乳腺癌的DIAPH3活性的抑制剂或调节剂。 因此,本发明还提供了在测定中使用DIAPH3或其片段鉴定此类化合物的方法。